Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 2
1994 1
1995 5
1996 5
1997 6
2006 1
2007 2
2013 2
2014 1
2015 2
2016 1
2017 2
2018 2
2019 3
2020 2
2021 2
2022 3
2023 2
2024 2
2025 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

47 results

Results by year

Filters applied: . Clear all
Page 1
In Reply.
Sancetta R. Sancetta R. Obstet Gynecol. 2019 Sep;134(3):648-649. doi: 10.1097/AOG.0000000000003440. Obstet Gynecol. 2019. PMID: 31441811 No abstract available.
Real-world efficacy and safety of luspatercept and predictive factors of response in patients with lower risk myelodysplastic syndromes with ring sideroblasts.
Lanino L, Restuccia F, Perego A, Ubezio M, Fattizzo B, Riva M, Consagra A, Musto P, Cilloni D, Oliva EN, Palmieri R, Poloni A, Califano C, Capodanno I, Itri F, Elena C, Fozza C, Pane F, Pelizzari AM, Breccia M, Di Bassiano F, Crisà E, Ferrero D, Giai V, Barraco D, Vaccarino A, Griguolo D, Minetto P, Quintini M, Paolini S, Sanpaolo G, Sessa M, Bocchia M, Di Renzo N, Diral E, Leuzzi L, Genua A, Guarini A, Molteni A, Nicolino B, Occhini U, Rivoli G, Bono R, Calvisi A, Castelli A, Di Bona E, Di Veroli A, Ferrara F, Fianchi L, Galimberti S, Grimaldi D, Marchetti M, Norata M, Frigeni M, Sancetta R, Selleri C, Tanasi I, Tosi P, Turrini M, Giordano L, Finelli C, Pasini P, Naldi I, Santini V, Della Porta MG; Fondazione Italiana Sindromi Mielodisplastiche (FISiM) Clinical network (https://www.fisimematologia.it/). Lanino L, et al. Among authors: sancetta r. Am J Hematol. 2023 Aug;98(8):E204-E208. doi: 10.1002/ajh.26960. Epub 2023 May 24. Am J Hematol. 2023. PMID: 37222267 Free article. No abstract available.
Real-World Efficacy Profile of Compassionate Use of Asciminib in an Italian, Multi-Resistant Chronic-Phase Chronic Myeloid Leukemia (CML-CP) Patient Population.
Breccia M, Rossi AR, Giai V, Martino B, Fava C, Annunziata M, Abruzzese E, Binotto G, Baratè C, Nardozza AP, Misto A, Coco P, Calafiore V, Carraro MC, Cattina F, Cavazzini F, Corsetti MT, Crucitti L, Crugnola M, Di Veroli A, Ditonno P, Ermacora A, Ferrara F, Genua A, Gozzini A, Impera S, Iurlo A, Levato L, Luciano L, Miggiano MC, De Gobbi M, Santoro M, Scappini B, Scortechini AR, Patriarca A, Rosati S, Russo S, Sancetta R, Sanpaolo G, Santeramo TM, Sibilla S, Sorà F, Sportoletti P, Stagno F, Trabacchi E, Castagnetti F. Breccia M, et al. Among authors: sancetta r. Hematol Oncol. 2025 May;43(3):e70101. doi: 10.1002/hon.70101. Hematol Oncol. 2025. PMID: 40344674 Free PMC article.
Burkitt lymphoma in adolescents and young adults: management challenges.
Dozzo M, Carobolante F, Donisi PM, Scattolin A, Maino E, Sancetta R, Viero P, Bassan R. Dozzo M, et al. Among authors: sancetta r. Adolesc Health Med Ther. 2016 Dec 23;8:11-29. doi: 10.2147/AHMT.S94170. eCollection 2017. Adolesc Health Med Ther. 2016. PMID: 28096698 Free PMC article. Review.
Minimal residual disease-driven treatment intensification with sequential addition of ibrutinib to venetoclax in R/R CLL.
Scarfò L, Heltai S, Albi E, Scarano E, Schiattone L, Farina L, Moia R, Deodato M, Ferrario A, Motta M, Reda G, Sancetta R, Coscia M, Rivela P, Laurenti L, Varettoni M, Perotta E, Capasso A, Ranghetti P, Colia M, Ghia P. Scarfò L, et al. Among authors: sancetta r. Blood. 2022 Dec 1;140(22):2348-2357. doi: 10.1182/blood.2022016901. Blood. 2022. PMID: 35921541 Free article.
Current and future management of Ph/BCR-ABL positive ALL.
Maino E, Sancetta R, Viero P, Imbergamo S, Scattolin AM, Vespignani M, Bassan R. Maino E, et al. Among authors: sancetta r. Expert Rev Anticancer Ther. 2014 Jun;14(6):723-40. doi: 10.1586/14737140.2014.895669. Epub 2014 Mar 10. Expert Rev Anticancer Ther. 2014. PMID: 24611626 Review.
The prognostic value of health-related quality of life for early molecular response in patients with chronic myeloid leukemia: analysis of the GIMEMA-SUSTRENIM trial.
Efficace F, Cannella L, Capodanno I, Sancetta R, Porcu V, Lunghi M, Biagi A, Castagnetti F, Caocci G, Baldi T, Marasca R, Bonifacio M, Gozzini A, Martino B, Sora F, Westerweel PE, Fazi P, Vignetti M, Pane F, Breccia M. Efficace F, et al. Among authors: sancetta r. Front Oncol. 2025 Aug 27;15:1645217. doi: 10.3389/fonc.2025.1645217. eCollection 2025. Front Oncol. 2025. PMID: 40936723 Free PMC article.
Unmet Needs and Their Impact on Quality of Life and Symptoms in Myelodysplastic Neoplasm Patients and Caregivers.
Crisà E, Cilloni D, Riva M, Balleari E, Barraco D, Manghisi B, Borin L, Calmasini M, Calvisi A, Capodanno I, Della Porta MG, Diral E, Fattizzo B, Fenu S, Paolini S, Finelli C, Fozza C, Frairia C, Giai V, Turrini M, Isoni MA, Itri F, Maurillo L, Molteni A, Palumbo GA, Pelizzari AM, Pilo F, Poloni A, Bosi C, Sanpaolo G, Sancetta R, Amato C, Santini V, Voso MT, Salek S, Ionova T, Nosari A, Oliva EN. Crisà E, et al. Among authors: sancetta r. Cancers (Basel). 2025 May 7;17(9):1587. doi: 10.3390/cancers17091587. Cancers (Basel). 2025. PMID: 40361511 Free PMC article.
47 results